• Due to the SLS content to be used as a soap substitute only.

• Hydromol® Ointment is made to the same formula and is more cost effective.

• This product is also known locally as ‘Emulsifying Ointment RVI
  Formula’. It is softer than emulsifying ointment BP. Epaderm ointment is
  made to the same formula, but is more expensive.

• Approved for used in radiotherapy only.

• SLS free alternative to Aqueous Cream.

• Alternative to Diprobase

• Alternative to E45® Cream.

• Alternative to Doublebase gel.

• Alternative to Aveeno

• Approved for the relief of dryness of the nose, lips and face when a patient is using oxygen via nasal prongs, CPAP masks etc

• For inpatient use only as per Trust Moisture-Associated Tissue Damage (MASD) guidelines

• 2g, 28g & 92g barrier cream, 28ml pump spray, sterile 1ml no
  sting barrier film foam applicator, sterile 3ml no sting
  barrier film foam applicator

• For limited use around gastrostomies when wound breakdown is thought to be aggravated by leakage of gastric acid.

- available as Dermacool

• Cream and ointment

• Cream 30g
• 15g available Over the Counter.

• Cream 30g (15g available Over the Counter) and Ointment 30g

• Cream and ointment

• Cream

• Cream and ointment

• Cream, ointment & scalp application

• Clobetasone butyrate 500mcg/1g, nystatin 100000iu/1g, oxytetracycline (as oxytetracycline calcium) 30mg/1g

• Ointment

• Cream, ointment & scalp application

• Cream and ointment

• 2.25mg medicated plasters

• Cream, ointment & gel

• Cream, ointment & scalp application

• Ointment

• Scalp application

• Approved for adults with severe chronic hand eczema that have not responded to potent topical corticosteroids in line with NICE.

• 0.005% Cream and ointment
  
  

• Calcipotriol 50mcg/1g and betamethasone (as betamethasone dipropionate) 500mcg/1g
  • Gel and ointment (Dovobet®)
    
    • approved for the treatment of scalp and mild to moderate non scalp plaque psoriasis vulgaris in adults.
  • 60g cutaneous spray (Enstilar®)
    
    • Approved for the treatment of plaque psoriasis
  • Cream (Wynzora®)

• 1% unlicensed
• 2% unlicensed
• 5% unlicensed

• 0.05%/3%

• 0.2%, 0.4% & 0.6% unlicensed

• 0.1%, 0.2%, 0.4%, 0.6%, 0.8%, 1%, 2%, 4%, 6% & 8%.

• 0.1%, 0.2%, 0.4%, 0.6%, 0.8%, 1%, 2%, 4%, 6%, 8% & 16%in emulsifying base.

• 2%, 5%, 10% and 20%.

• 10mg and 25mg capsules 

• 30mg & 120mg tablets

• Approved for the treatment of moderate to severe atopic dermatitis in line with NICE

• Approved for psoriasis in line with NICE.
• Approved for the treatment of moderate to severe hidradenitis suppurativa in line with NICE and NHS England Commissioning Policy
• Approved for the treatment of plaque psoriasis in children and young people in line with NICE 

Biosimilars are available – note that indications can differ between different products – prescribe by brand. Consult with individual trust pharmacy department for details of
preferred biosimilar brand.

• 10mg, 20mg & 30mg tablets
• To be used in accordance with NICE guidance

• Approved for treating moderate to severe atopic dermatitis in adults in line with NICE.

• 160mg/ml solution pre-filled pen/syringe
• Approved for the treatment of moderate to severe plaque psoriasis in line with NICE

• 210mg/1.5ml solution for injection in pre-filled syringes.
• Approved for the treatment of moderate to severe plaque psoriasis in line with NICE 

• Capsules & SF Solution 
  See section 8.2.2

• 6mg tablets
• Approved for the treatment of moderate to severe plaque psoriasis in line with NICE

• 120mg tablets
• Approved for the treatment of moderate to severe plaque psoriasis in line with NICE

• 200mg/1.14ml & 300mg/2ml solution for injection
• Approved for treating moderate to severe atopic dermatitis in adults in line with NICE

• Approved for psoriasis in line with NICE
• Approved for the treatment of plaque psoriasis in children and young people in line with NICE

Biosimilars are available – note that indications can differ between different products – prescribe by brand. Consult with individual trust pharmacy department for details of
preferred biosimilar brand.

• 100mg/1mL solution for injection
• Approved for the treatment of moderate to severe plaque psoriasis in line with NICE

• Approved for psoriasis in line with NICE.

• Approved for the treatment of moderate to severe plaque psoriasis in adults in line with NICE

• Approved for treating moderate to severe atopic dermatitis in people 12 years and over in line with NICE

• See section 08.01.03
• 2.5mg tablets

• 1% cream
  • Approved of moderate atopic eczema on the face and neck in children between 2 and 16 years in line NICE.
  • Can be initiated by prescribers (including general practitioners) with a special interest and experience in dermatology and only after careful discussion with the patient about the potential risks and benefits of all appropriate second-line treatment options.

• Approved for the treatment of moderate to severe plaque psoriasis in line with NICE

• 50mg hard capsules
• Currently awaiting assessment against NENC ICB ethical framework in December 2024

• Approved for the treatment of plaque psoriasis in line with NICE.
• Approved for the treatment of moderate to severe plaque psoriasis in children and young people in line with NICE
• Approved for treating moderate to severe hidradenitis suppurativa in  line with NICE

• 0.03% & 0.1% ointment
  • Approved for moderate to severe atopic eczema in patients over 2 years in line with NICE.
  • Can be initiated by prescribers (including general practitioners) with a special interest and experience in dermatology and only after careful discussion with the patient about the potential risks and benefits of all appropriate second-line treatment options

• 100 mg solution for injection in pre-filled syringe
• Approved for the treatment of moderate to severe plaque psoriasis in line with NICE

• Approved for the treatment of moderate to severe atopic dermatitis in line with NICE

• Approved for the treatment of moderate to severe atopic dermatitis in line with NICE

• 45mg & 90mg SC injections approved for psoriasis in line with NICE.
• Approved for the treatment of plaque psoriasis in children and young people in line with NICE

• adapalene 0.1%/benzoyl peroxide 2.5% & adapelene 0.3%/benzoyl peroxide 2.5%

• 15% (Finacea®) and 20% (Skinoren®) gel 

• 1% topical solution (alcohol – water basis)
• 1% lotion (aqueous)

• For specialist initiation for the treatment of severe rosacea. Following specialist review of effectiveness, primary care can continue supply.

• For the treatment of papulopustular rosacea in patients as second line treatment in patient who have failed topical metronidazole.

• Tablets containing cyproterone acetate 2mg & ethinylestradiol 35 micrograms.
• Note: generic co-cyprindiol is much cheaper than Dianette®

• Tablets containing cyproterone acetate 2mg & ethinylestradiol 35 micrograms
  – generic co-cyprindiol is much cheaper than Dianette®

• 5mg, 10mg, 20mg & 40mg capsules
• Isotretinoin is a toxic drug only to be prescribed by or under the supervision of a consultant dermatologist – see BNF and product literature.
• Drug Safety Updates can be found via the following link:
  • MHRA Isotretinoin Drug Safety Updates

See section 13.5.2

In flexible collodion

• 6 inch applicator
• 95% pencils
• 0.5% solution 

• 10%, 75% & 90% solution.

• Second line specialist use for treatment of ano-genital warts (mainly in genitourinary medicine [GUM] clinics).
•  For the management of actinic keratosis.

•  ACBS

•  ACBS

• For the treatment of superficial malignant and premalignant skin lesions.

• Tablets containing cyproterone acetate 2mg & ethinylestradiol 35 micrograms.
• Note: generic co-cyprindiol is much cheaper than Dianette®

• **UNDER REVIEW**
• Approved for use as a second-line treatment of facial hirsutism in patients where co-cyprindiol is ineffective, contra-indicated or considered inappropriate. Treatment should be initiated by or on the specific advice of an appropriate specialist - endocrinologist (or gynaecologist).

•  Unlicensed
• Potassium Iodide 60mg and 300mg capsules
• Approved for neutrophilic dermatoses (Sweet syndrome and pyoderma gangrenosum) and panniculitis (including erythema nodosum and nodular vasculitis)
• Dermatology only

• For limited use in burns/plastic surgery patients only.

• Cream and ointment

Cream & gel

• 2% cream
• shampoo

• 3mg tablets 
  • Approved for the treatment of scabies in accordance with DHSC Medicine Supply Notification
  • Note: The licensed preparation is currenly only avialable from Alliance.   

• For use in ENT surgery & epistaxis
  1.25cm x 100cm & 2.5cm x 100cm impregnated gauze
  

• See 13.10.05 skin tissue adhesives (Liquiband®, Liquiband Optima®, IndermilX-Fine, Histoacryl Blue®)

• 2.5% castor oil & colophony 2.5% in a collodion base.

• 2ml, 4ml & 10ml prefilled syringe.
• For use in plastic surgery to close dead spaces, adhere skin graft, close simple wounds and stabilise bone grafts.

• For use in neurosurgery and vascular surgery.

2ml and 5ml kit

• 2ml, 4ml & 10ml kit
• Also approved for use in the treatment of mesh fixation in hernia repair.

• 4.8 & 9.5 cm 2 Haemostatic (collagen sponge coated with fibrinogen and thrombin) - for use in liver and renal surgery.

Containing 70% isopropyl alcohol or methylated spirit (e.g. Clini-wipes®, Alcowipes®)

70% liquid & 70% spray

• Sterile solution – bottles
• 25ml & 100ml sachets(Normasol®)

• 0.05% solutions, 25ml & 100ml sachets 
• 0.5% solution in 70% methylated spirit (pink, colourless & red staining)
• 2.5% in 70% methylated spirit wipes
• 0.5% hand rub (contains 70% isopropyl alcohol + emollients)
• 4% surgical scrub
• 2% in 70% isopropyl alcohol wipes (Clinell®)
• Skin swabs & skin cleanser
• 3ml & 10.5ml applicators (Chloraprep®)
• 1% Obstetric cream

• Solution containing Betaine 0.1% (surfactant) and Polyhexanide 0.1% (a chlorhexidine polymer). Mainly for use from 40ml plastic ampoules.
  Also available as a gel. 
• To be prescribed/used only on the advice of tissue viability specialists.

• Secondary care use only

• Used in some trusts as an alternative to chlorhexidine scrub and Triclosan skin cleanser in MRSA prophylaxis/eradication on secondary care advice.

• 2.5% dry powder spray
• 10% alcoholic solution
• 7.5% surgical scrub
• 10% antiseptic solution (aqueous)
• 0.35% sterile aqueous solution 
  
  • approved for use in the prevention of surgical site infection in arthroplasty. 
  
  

• 1% sterilising solution.

• 10 volume (3%) & 20 volume (6%) solutions.

• 5% solution unlicensed
• 400mg tablets  

• Potassium permanganate not to be issued on repeat prescription 

• For limited use in some operating theatres only.

• For limited use in some operating theatres/critical care areas only.

Paint containing magenta 0.4%, boric acid 0.8%, phenol 0.004%, resorcinol 8%, acetone and alcohol (or industrial methylated spirit).

• Aluminium chloride hexahydrate 20% solution in an alcoholic basis

• 100 unit vials for injection (Botox) – see section 4.9.3

• For limited use as an alternative to surgery in some patients.

•  To be initiated by specialist.

• 50mcg/1ml solution for injection
• Approved for pruritus in adults with chronic kidney disease having haemodialysis in line with NICE